Browse by Current Cardiff authors
Number of items: 6.
Gillespie, David, Farewell, Daniel, Barrett-Lee, Peter, Casbard, Angela, Hawthorne, Anthony Barney, Hurt, Christopher, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza
2017.
The use of randomisation-based efficacy estimators in non-inferiority trials.
Trials
18
(1)
, 117.
10.1186/s13063-017-1837-3
|
|
Alhadj Ali, M., Bowen-Morris, J., Gee, N. Tze, Stenson, R., Walkey, H., Littlemore, K. and Dayan, C.
2017.
Use of a “YouTube” style video clip to raise interest amongst young people with new‐onset Type 1 diabetes in immunotherapy trials [Abstract].
Diabetic Medicine
34
(S1)
, P315.
10.1111/dme.24_13304
|
|
Gillespie, David, Hood, Kerenza, Farewell, Daniel, Hawthorne, Antony, Hurt, Chris Nicholas, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter, Casbard, Angela C. and Murray, Nick
2015.
The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation].
Trials
16
(Suppl)
, P129.
10.1186/1745-6215-16-S2-P129
|
|
Gillespie, David, Hood, Kerenza, Farewell, Daniel, Stenson, Rachel, Probert, Christopher and Hawthorne, A. Barney
2014.
Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis.
Inflammatory Bowel Diseases
20
(1)
, pp. 82-91.
10.1097/01.MIB.0000437500.60546.2a
|
|
Hawthorne, A. B., Stenson, Rachel, Gillespie, David, Swarbrick, Edwin T., Dhar, Anjan, Kapur, Kapil C., Hood, Kerenza and Probert, Chris S. J.
2012.
One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis.
Inflammatory Bowel Diseases
18
(10)
, pp. 1885-1893.
10.1002/ibd.21938
|
|
This list was generated on Tue Mar 2 03:59:49 2021 GMT.